Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho-ichi Yamagishi

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|August 2, 2019
Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic InterventionSho-Ichi Yamagishi
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 4, 2009
Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complicationsSho-ichi Yamagishi
Clinical Calcium|July 1, 2014
[Bone metabolism and cardiovascular function update. Impairment of osteo-vascular interaction by glyco-oxidative stress]Sho Ichi Yamagishi
Experimental Gerontology|November 30, 2010
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetesSho-ichi Yamagishi
Clinical Calcium|January 6, 2010
[Calcium antagonists: current and future applications based on new evidence. Calcium antagonists and diabetes]Sho-ichi Yamagishi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Diabetic macrovascular complications]Sho-ichi Yamagishi
Rejuvenation Research|September 7, 2012
Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disordersSho-ichi Yamagishi
Cardiovascular Diabetology|January 30, 2019
Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillationSho-Ichi Yamagishi
Current Drug Targets|October 26, 2011
Role of advanced glycation end products (AGEs) in osteoporosis in diabetesSho-ichi Yamagishi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Glycation]Sho-ichi Yamagishi
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
Circulation Journal : Official Journal of the Japanese Circulation Society|August 2, 2019
Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic InterventionSho-Ichi Yamagishi
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 4, 2009
Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complicationsSho-ichi Yamagishi
Clinical Calcium|July 1, 2014
[Bone metabolism and cardiovascular function update. Impairment of osteo-vascular interaction by glyco-oxidative stress]Sho Ichi Yamagishi
Experimental Gerontology|November 30, 2010
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetesSho-ichi Yamagishi
Clinical Calcium|January 6, 2010
[Calcium antagonists: current and future applications based on new evidence. Calcium antagonists and diabetes]Sho-ichi Yamagishi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Diabetic macrovascular complications]Sho-ichi Yamagishi
Rejuvenation Research|September 7, 2012
Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disordersSho-ichi Yamagishi
Cardiovascular Diabetology|January 30, 2019
Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillationSho-Ichi Yamagishi
Current Drug Targets|October 26, 2011
Role of advanced glycation end products (AGEs) in osteoporosis in diabetesSho-ichi Yamagishi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Glycation]Sho-ichi Yamagishi
Pageof 40